COMMUNIQUÉS West-GlobeNewswire

Corbus Pharmaceuticals to Host Conference Call to Discuss Topline Data from CANYON-1 Clinical Trial and the Potential of CRB-913 In Obesity
11/09/2026
Virtual Webcast to be Held Monday, September 14, 2026, at 8:00 AM EDT NORWOOD, Mass., Sept. 11, 2026 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP), a clinical-stage company focused on [...]
Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
11/09/2026
CAMBRIDGE, Mass., Sept. 11, 2026 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a biopharmaceutical company leveraging a novel Oligonucleotide Promoted Editing of RNA (OPERA ® ) platform to develop a new [...]
Impact BioMedical Inc (NYSE American: IBO) Announces 1 for 12.62 Reverse Stock Split to Pursue Completion of Merger with Zoar Ltd. (previously Dr. Ashley’s Ltd.)
11/09/2026
HOUSTON, Sept. 11, 2026 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (the “ Company ”) today announced that the Company's Board of Directors has approved a 1 for 12.62 reverse stock split of the Company's issued and [...]
4DMT Announces New Employment Inducement Grants
11/09/2026
EMERYVILLE, Calif., Sept. 11, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with [...]
Agomab Announces Appointments of Marino Garcia and Dr. Naimish Patel to Board of Directors
11/09/2026
Antwerp, Belgium, September 11, 2026 – Agomab Therapeutics NV (Nasdaq: AGMB) (“Agomab” or the “Company”), a clinical-stage biopharmaceutical company focused on fibro-inflammatory diseases, today announced that [...]
MaxCyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/09/2026
ROCKVILLE, Md., Sept. 11, 2026 (GLOBE NEWSWIRE) -- MaxCyte, Inc. (Nasdaq: MXCT), a leading cell-engineering focused company providing enabling platform technologies to advance the discovery, development and [...]
Cellectis organise une conférence téléphonique et un webcast le 14 septembre pour présenter un point d’activité
11/09/2026
NEW YORK, 11 sept. 2026 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth : ALCLS ; Nasdaq : CLLS), société de biotechnologie de stade clinique, qui utilise sa plateforme pionnière d'édition de génome pour développer des [...]
Cellectis to Host Conference Call and Webcast on September 14 to Provide a Business Update
11/09/2026
NEW YORK, Sept. 11, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to develop life-saving [...]
Interim results for the six months ended June 30, 2026
11/09/2026
September 11, 2026 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Interim results for the six months ended June 30, 2026 Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), a clinical-stage biopharmaceutical company [...]
The GLP-1 Boom Is Bypassing Latino Patients; Bilingual Telehealth Clinic Sol y Vida Launches to Change That
11/09/2026
— Latino-founded, LegitScript-certified clinic opens for Hispanic Heritage Month with licensed clinicians, published prices and care in Spanish — “recetado, no comprado” — LOS ANGELES, CA, Sept. 12, 2026 (GLOBE NEWSWIRE [...]
Gartner Names ABBYY a Leader in its 2026 Magic Quadrant for Intelligent Document Processing
11/09/2026
AUSTIN, Texas, Sept. 11, 2026 (GLOBE NEWSWIRE) -- ABBYY has been named a Leader in the 2026 Gartner Magic Quadrant for Intelligent Document Processing (IDP). It is ABBYY's second recognition in the Gartner second [...]
FDA approves Pharming’s Joenja® as first treatment for children with APDS in the U.S.
11/09/2026
FDA approval expands Joenja indication to include children with activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS) ages 4 to 11 who weigh at least 27kg Newly approved Joenja doses are expected to be [...]
Omniscient Secures Third FDA Clearance, Extending Its Connectomic Platform into the Fast-Growing Deep Brain Stimulation Market
11/09/2026
The clearance of Quicktome’s Deep Brain (DB) workflow marks Omniscient's third FDA milestone and its entry into DBS, advancing the company's strategy to provide actionable brain insights across neurosurgery and [...]
MEDIA ADVISORY: New Report Tracking Under-Used Hospitals, Deficits, Cuts & Inequities in Health Care Across Ontario
11/09/2026
Attn: Assignment Editor/News Desk TORONTO, Sept. 11, 2026 (GLOBE NEWSWIRE) -- The Ford government has continued to expand its privatization of local public hospitals' services. A raft of new private clinics is planned [...]
Erica Zarkovich, Chief Market and Partnerships Officer, Named One of Canada’s Most Powerful Women: Top 100
11/09/2026
Toronto, Canada, Sept. 11, 2026 (GLOBE NEWSWIRE) -- Erica Zar kovich, Chief Market and Partnerships Officer, has been named one of Canada’s Most Powerful Women: Top 100 by WXN Media in the CN Executive Leaders category [...]
Orion Corporation: Acquisition of own shares during week 37, 2026
11/09/2026
Orion Corporation: Acquisition of own shares during week 37, 2026 The share buybacks form part of the share buyback programme that Orion Corporation announced on 27 August 2026. The buyback programme runs from 1 [...]
Sanofi: Informations relatives au nombre de droits de vote et d'actions - AOUT 2026
11/09/2026
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés Financiers Sanofi Société [...]
Sanofi: Information concerning the total number of voting rights and shares - August 2026
11/09/2026
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’ [...]
Outlook Therapeutics Fireside Chat from H.C. Wainwright Conference Now Available On-Demand
11/09/2026
Fireside chat featuring Bob Jahr, Chief Executive Officer, and H.C. Wainwright Managing Director & Senior Biotechnology Equity Research Analyst Access the video webcast here ISELIN, N.J., Sept. 11, 2026 (GLOBE [...]

Pages